Slovom lymf\u00f3m sa v\u0161eobecne ozna\u010duje ako n\u00e1dorov\u00e9 ochorenie lymfatick\u00e9ho syst\u00e9mu.<\/p>\n
Od in\u00fdch n\u00e1dorov\u00fdch ochoren\u00ed sa l\u00ed\u0161i predov\u0161etk\u00fdm t\u00fdm, \u017ee postihuje nielen star\u0161ie osoby, ale aj mlad\u00fdch dospel\u00fdch jedincov. Rizikov\u00fa skupinu teda tvoria mlad\u00ed \u013eudia vo veku medzi 20 a 30 rokmi. Lymf\u00f3my sa pritom objavuj\u00fa o nie\u010do m\u00e1lo \u010dastej\u0161ie u mu\u017eov ako u \u017eien, v pomere asi 3: 1. Lymfatick\u00fd syst\u00e9m je tvoren\u00fd okrem in\u00e9ho sie\u0165ou lymfatick\u00fdch uzl\u00edn a ciev, a predov\u0161etk\u00fdm ur\u010dit\u00fdm typom bielych krviniek, nazvan\u00fdmi lymfocyty. Lymfocyty sa pritom e\u0161te \u010falej delia na viac r\u00f4znych podtypov:<\/p>\n
T-lymfocyty<\/strong> maj\u00fa za \u00falohu dohliada\u0165 na imunitn\u00fd syst\u00e9m organizmu. Sp\u00fa\u0161\u0165aj\u00fa imunitn\u00e9 reakcie a kontroluj\u00fa ich intenzitu, v pr\u00edpade potreby dok\u00e1\u017eu neutralizova\u0165 r\u00f4zne typy cudzorod\u00fdch elementov.<\/p>\n B-lymfocyty<\/strong> vytv\u00e1raj\u00fa protil\u00e1tky. Aktivuj\u00fa sa napr\u00edklad pri o\u010dkovan\u00ed.<\/p>\n NK-lymfocyty<\/strong> zase ni\u010dia v\u0161etky bunky v tele, ktor\u00e9 vykazuj\u00fa nejak\u00fa abnormalitu (napr\u00edklad bunky napadnut\u00e9 v\u00edrusmi alebo n\u00e1dorov\u00e9 bunky). V\u0161etky uveden\u00e9 typy lymfocytov sa m\u00f4\u017eu sta\u0165 podkladom pre vznik lymf\u00f3mu – zvy\u010dajne v jednej alebo viacer\u00fdch lymfatick\u00fdch uzlin\u00e1ch. Akon\u00e1hle sa za\u010dn\u00fa abnorm\u00e1lne bunky nekontrolovane mno\u017ei\u0165, prev\u00fd\u0161i postupom \u010dasu svojim po\u010dtom po\u010det norm\u00e1lnych buniek lymfatickej uzliny, \u010d\u00edm sp\u00f4sob\u00ed jej zv\u00e4\u010d\u0161enie. Postupom \u010dasu sa m\u00f4\u017ee n\u00e1dorov\u00e9 bujnenie roz\u0161\u00edri\u0165 do \u010fal\u0161\u00edch lymfatick\u00fdch uzl\u00edn, pr\u00edpadne aj do ostatn\u00fdch org\u00e1nov lymfatick\u00e9ho syst\u00e9mu ako je slezina alebo kostn\u00e1 dre\u0148.<\/p>\n Existuje pomerne \u0161irok\u00e1 rada r\u00f4znych typov lymf\u00f3mov, pri\u010dom ka\u017ed\u00fd z nich vykazuje trochu odli\u0161n\u00e9 spr\u00e1vanie. Pre spr\u00e1vnu vo\u013ebu lie\u010debn\u00e9ho postupu je teda nesmierne d\u00f4le\u017eit\u00e9 spr\u00e1vne ur\u010di\u0165 konkr\u00e9tny typ lymf\u00f3mu u ka\u017ed\u00e9ho pacienta. Naj\u010dastej\u0161ie sa pou\u017e\u00edva z\u00e1kladn\u00e9 rozdelenie na dva typy: Hodgkinov lymf\u00f3m, pomenovan\u00fd po anglickom lek\u00e1rovi z 19. storo\u010dia, a skupinu Non-Hodkginsk\u00fdch lymf\u00f3mov.<\/p>\n Ke\u010f\u017ee m\u00f4\u017eu lymf\u00f3my vznikn\u00fa\u0165 na viacer\u00fdch r\u00f4znych miestach v tele, r\u00f4zne s\u00fa aj ich pr\u00edznaky. V\u0161eobecne sa v\u0161ak v\u00e4\u010d\u0161ina lymf\u00f3mov prejavuje nebolestiv\u00fdm zv\u00e4\u010d\u0161en\u00edm lymfatick\u00fdch uzl\u00edn. Nu\u017e, tento jav sprev\u00e1dza aj mnoh\u00e9 in\u00e9, menej z\u00e1va\u017en\u00e9 ochorenia a ned\u00e1 sa teda poveda\u0165, \u017ee zv\u00e4\u010d\u0161en\u00e9 uzliny automaticky znamenaj\u00fa pr\u00edtomnos\u0165 lymf\u00f3mu – tu m\u00f4\u017eu spo\u013eahlivo potvrdi\u0165 \u010di vyvr\u00e1ti\u0165 histologick\u00e9 testy. \u010eal\u0161ie mo\u017en\u00e9 sprievodn\u00e9 javy, ktor\u00e9 sa m\u00f4\u017eu pri lymf\u00f3mu objavi\u0165:<\/p>\n Slovom lymf\u00f3m sa v\u0161eobecne ozna\u010duje ako n\u00e1dorov\u00e9 ochorenie lymfatick\u00e9ho syst\u00e9mu. Od in\u00fdch n\u00e1dorov\u00fdch ochoren\u00ed sa l\u00ed\u0161i predov\u0161etk\u00fdm t\u00fdm, \u017ee postihuje nielen star\u0161ie osoby, ale aj mlad\u00fdch dospel\u00fdch jedincov. Rizikov\u00fa skupinu teda tvoria mlad\u00ed \u013eudia vo veku medzi 20 a 30 rokmi. Lymf\u00f3my sa pritom objavuj\u00fa o nie\u010do m\u00e1lo \u010dastej\u0161ie u mu\u017eov ako u \u017eien, v pomere asi 3: 1. Lymfatick\u00fd…<\/p>\n","protected":false},"author":9,"featured_media":2948,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[],"class_list":["post-3614","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/posts\/3614","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/comments?post=3614"}],"version-history":[{"count":2,"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/posts\/3614\/revisions"}],"predecessor-version":[{"id":3616,"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/posts\/3614\/revisions\/3616"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/media\/2948"}],"wp:attachment":[{"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/media?parent=3614"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/categories?post=3614"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ptc.cz\/sk\/wp-json\/wp\/v2\/tags?post=3614"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}Druhy lymf\u00f3mov<\/h2>\n
Pr\u00edznaky ochorenia lymf\u00f3mom<\/h2>\n
\n